Alnylam Pharmaceuticals EV to EBIT (TTM)
View 4,000+ financial data types
Alnylam Pharmaceuticals EV to EBIT (TTM) Chart
Alnylam Pharmaceuticals Historical EV to EBIT (TTM) DataPro Export Data Date Range:
|Data for this Date Range|
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
About EV / EBIT
Enterprise value of a company divided by its Earnings Before Interest Taxes (TTM).
EV/EBIT answers the question "What is a company being valued per each dollar of EBIT?" A high (low) EV/EBIT mean the company is potentially overvalued (undervalued).
EV/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.
Other similar metrics include :
EV/EBITDA : How much is each dollar of EBITDA worth to investors?
EV/Revenues : Or each dollar of Revenues?
EV/Free Cash Flow : Or each dollar of FCF?
For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
ALNY EV to EBIT (TTM) Benchmarks
|Alexion Pharmaceuticals||Go Pro|
|Isis Pharmaceuticals||Go Pro|
Yahoo 03/07 14:31 ET
Yahoo 03/07 14:10 ET
noodls 03/06 18:35 ET
Yahoo 03/06 08:09 ET
Street Insider 03/06 08:01 ET
Yahoo 03/05 11:50 ET
Zacks 03/03 10:52 ET